GlassScriptPhysician profile
Yuri Genyk
NPI 1225064538
$35,215.35
in general payments reported to CMS, 2019-2025
8 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,275 · 2020: $16K · 2021: $19.94 · 2022: $12K · 2024: $3,738 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,230 · Education: $1,000 · Food and Beverage: $687 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,229.92 |
| Education | $1,000.00 |
| Food and Beverage | $687.37 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $20,650.00 | 2020-2022 | |
| Baxter Healthcare | $7,035.00 | 2019-2020 | |
| Intuitive Surgical, INC. | $6,151.20 | 2019-2024 | |
| Histosonics, INC. | $1,107.58 | 2024 | |
| Dilon Technologies, INC. | $187.97 | 2025 | Hemoblast Bellows |
| Misonix INC | $63.66 | 2019-2020 | |
| Boston Scientific Corporation | $19.94 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuri Genyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.